5PSQ-067 Analysis of antineoplastic drugs preparation errors as a first step to improve the quality of the process

BACKGROUND: Antineoplastic preparation presents unique safety concerns because of its toxicity and narrow therapeutic window. Moreover, the antineoplastic use system includes several stages that are vulnerable to opportunities for potentially harmful medication errors. PURPOSE: To identify the type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Alfaro, B Marzal, Escudero-Vilaplana, V, Rodríguez-González, CG, Peña, E González-Haba, García-González, X, Ibañez-García, S, García-Moreno, FJ, Ortega-Navarro, C, Iglesias-Peinado, I, Herranz, A, Sanjurjo-Saez, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535736/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados